FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Sep 20, 2011
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on September 20, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc.
- Inspection Date
- September 20, 2011
- Product Type
- Biologics
View Company Profile
ID · 75a1483f-2a61-4661-84b0-11d22d24148e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 745721
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.100(b)Written SOPs available for use by personnel
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 13, 2024 | VAI | Detroit District Office | Blood and Blood Products |
| June 6, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 18, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 25, 2009 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1256896 - 2024-12-13
- FDA Inspection 1094894 - 2019-06-06
- FDA Inspection 945499 - 2015-09-18
- FDA Inspection 573575 - 2009-03-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.